KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Accumulated Expenses (2018 - 2026)

Castle Biosciences' Other Accumulated Expenses history spans 8 years, with the latest figure at $8.9 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 11.81% to $8.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.9 million, a 11.81% increase, with the full-year FY2025 number at $8.9 million, up 11.81% from a year prior.
  • Other Accumulated Expenses hit $8.9 million in Q4 2025 for Castle Biosciences, up from $8.9 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for CSTL hit a ceiling of $8.9 million in Q4 2025 and a floor of $2.0 million in Q1 2021.
  • Historically, Other Accumulated Expenses has averaged $6.4 million across 5 years, with a median of $7.0 million in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 223.84% in 2022 and later dropped 10.51% in 2023.
  • Tracing CSTL's Other Accumulated Expenses over 5 years: stood at $5.7 million in 2021, then fell by 7.33% to $5.3 million in 2022, then soared by 39.05% to $7.3 million in 2023, then grew by 9.24% to $8.0 million in 2024, then rose by 11.81% to $8.9 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CSTL at $8.9 million in Q4 2025, $8.9 million in Q3 2025, and $8.2 million in Q2 2025.